202 related articles for article (PubMed ID: 31747372)
21. In Search of Enzymes with a Role in 3', 5'-Cyclic Guanosine Monophosphate Metabolism in Plants.
Gross I; Durner J
Front Plant Sci; 2016; 7():576. PubMed ID: 27200049
[TBL] [Abstract][Full Text] [Related]
22. The Endothelium-Dependent Nitric Oxide-cGMP Pathway.
Mónica FZ; Bian K; Murad F
Adv Pharmacol; 2016; 77():1-27. PubMed ID: 27451093
[TBL] [Abstract][Full Text] [Related]
23. Modulation of cGMP in heart failure: a new therapeutic paradigm.
Boerrigter G; Lapp H; Burnett JC
Handb Exp Pharmacol; 2009; (191):485-506. PubMed ID: 19089342
[TBL] [Abstract][Full Text] [Related]
24. Whole brain spheroid cultures as a model to study the development of nitric oxide synthase-guanylate cyclase signal transduction.
Teunissen CE; Steinbusch HW; Markerink-van Ittersum M ; De Bruijn C ; Axer H; De Vente J
Brain Res Dev Brain Res; 2000 Dec; 125(1-2):99-115. PubMed ID: 11154766
[TBL] [Abstract][Full Text] [Related]
25. Guanylyl Cyclase-cGMP Signaling Pathway in Melanocytes: Differential Effects of Altered Gravity in Non-Metastatic and Metastatic Cells.
Ivanova K; Hemmersbach R
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046325
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide-evoked transient kinetics of cyclic GMP in vascular smooth muscle cells.
Cawley SM; Sawyer CL; Brunelle KF; van der Vliet A; Dostmann WR
Cell Signal; 2007 May; 19(5):1023-33. PubMed ID: 17207606
[TBL] [Abstract][Full Text] [Related]
27. Activation of the nitric oxide-cGMP pathway reduces phasic contractions in neonatal rat bladder strips via protein kinase G.
Artim DE; Kullmann FA; Daugherty SL; Wu HY; de Groat WC
Am J Physiol Renal Physiol; 2009 Aug; 297(2):F333-40. PubMed ID: 19493964
[TBL] [Abstract][Full Text] [Related]
28. cGMP Imaging in Brain Slices Reveals Brain Region-Specific Activity of NO-Sensitive Guanylyl Cyclases (NO-GCs) and NO-GC Stimulators.
Peters S; Paolillo M; Mergia E; Koesling D; Kennel L; Schmidtko A; Russwurm M; Feil R
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30087260
[TBL] [Abstract][Full Text] [Related]
29. Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases.
Dupont LL; Glynos C; Bracke KR; Brouckaert P; Brusselle GG
Pulm Pharmacol Ther; 2014 Oct; 29(1):1-6. PubMed ID: 25043200
[TBL] [Abstract][Full Text] [Related]
30. In vivo reconstitution of the negative feedback in nitric oxide/cGMP signaling: role of phosphodiesterase type 5 phosphorylation.
Mullershausen F; Russwurm M; Koesling D; Friebe A
Mol Biol Cell; 2004 Sep; 15(9):4023-30. PubMed ID: 15240816
[TBL] [Abstract][Full Text] [Related]
31. A cell-based cGMP assay useful for ultra-high-throughput screening and identification of modulators of the nitric oxide/cGMP pathway.
Wunder F; Stasch JP; Hütter J; Alonso-Alija C; Hüser J; Lohrmann E
Anal Biochem; 2005 Apr; 339(1):104-12. PubMed ID: 15766716
[TBL] [Abstract][Full Text] [Related]
32. Nocturnal accumulation of cyclic 3',5'-guanosine monophosphate (cGMP) in the chick pineal organ is dependent on activation of guanylyl cyclase-B.
Olcese J; Majora C; Stephan A; Müller D
J Neuroendocrinol; 2002 Jan; 14(1):14-8. PubMed ID: 11903808
[TBL] [Abstract][Full Text] [Related]
33. Zhenwu decoction ameliorates cardiac hypertrophy through activating sGC (soluble guanylate cyclase) - cGMP (cyclic guanosine monophosphate) - PKG (protein kinase G) pathway.
Chen L; Zhou X; Deng Y; Yang Y; Chen X; Chen Q; Liu Y; Fu X; Kwan HY; You Y; Jin W; Zhao X
J Ethnopharmacol; 2023 Jan; 300():115705. PubMed ID: 36099983
[TBL] [Abstract][Full Text] [Related]
34. Role of the NO-GC/cGMP signaling pathway in platelet biomechanics.
Balmes A; Rodríguez JG; Seifert J; Pinto-Quintero D; Khawaja AA; Boffito M; Frye M; Friebe A; Emerson M; Seta F; Feil R; Feil S; Schäffer TE
Platelets; 2024 Dec; 35(1):2313359. PubMed ID: 38353233
[TBL] [Abstract][Full Text] [Related]
35. cGMP: transition from bench to bedside: a report of the 6th International Conference on cGMP Generators, Effectors and Therapeutic Implications.
Hoffmann LS; Chen HH
Naunyn Schmiedebergs Arch Pharmacol; 2014 Aug; 387(8):707-18. PubMed ID: 24927824
[TBL] [Abstract][Full Text] [Related]
36. Regulation of nitric oxide-sensitive guanylyl cyclase.
Friebe A; Koesling D
Circ Res; 2003 Jul; 93(2):96-105. PubMed ID: 12881475
[TBL] [Abstract][Full Text] [Related]
37. Systems Pharmacology and Rational Polypharmacy: Nitric Oxide-Cyclic GMP Signaling Pathway as an Illustrative Example and Derivation of the General Case.
Garmaroudi FS; Handy DE; Liu YY; Loscalzo J
PLoS Comput Biol; 2016 Mar; 12(3):e1004822. PubMed ID: 26985825
[TBL] [Abstract][Full Text] [Related]
38. Role of sGC-dependent NO signalling and myocardial infarction risk.
Wobst J; Kessler T; Dang TA; Erdmann J; Schunkert H
J Mol Med (Berl); 2015 Apr; 93(4):383-94. PubMed ID: 25733135
[TBL] [Abstract][Full Text] [Related]
39. Effect of nitric oxide on the cyclic guanosine monophosphate (cGMP) pathway during meiosis resumption in bovine oocytes.
Schwarz KR; Pires PR; Mesquita LG; Chiaratti MR; Leal CL
Theriogenology; 2014 Mar; 81(4):556-64. PubMed ID: 24331454
[TBL] [Abstract][Full Text] [Related]
40. cGMP becomes a drug target.
Schlossmann J; Schinner E
Naunyn Schmiedebergs Arch Pharmacol; 2012 Mar; 385(3):243-52. PubMed ID: 22297800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
